{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:12:17Z","timestamp":1784110337072,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170524"],"award-info":[{"award-number":["82170524"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31901039"],"award-info":[{"award-number":["31901039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Medical Research (No.2018-7) CAMS Innovation Fund for Medical Sciences"},{"name":"National High Level Hospital Clinical Research Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,8,5]]},"DOI":"10.1038\/s41416-026-03434-w","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:59:35Z","timestamp":1777964375000},"page":"394-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary proteome and metabolome uncover tumor microenvironment and cellular metabolism changes of renal clear cell carcinoma"],"prefix":"10.1038","volume":"135","author":[{"given":"Xiaoyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongxu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-6832","authenticated-orcid":false,"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"3434_CR1","unstructured":"Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39:2022-vol3."},{"key":"3434_CR2","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1007\/s00261-023-04034-5","volume":"48","author":"YW Hao","year":"2023","unstructured":"Hao YW, Zhang Y, Guo HP, Xu W, Bai X, Zhao J, et al. Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score. Abdom Radiol. 2023;48:3714\u201327.","journal-title":"Abdom Radiol"},{"key":"3434_CR3","doi-asserted-by":"crossref","unstructured":"Monjaras-Avila CU, Lorenzo-Leal AC, Luque-Badillo AC, D\u2019Costa N, Chavez-Mu\u00f1oz C, Bach H. The tumor immune microenvironment in clear cell renal cell carcinoma. Int J Mol Sci. 2023;24:7946.","DOI":"10.3390\/ijms24097946"},{"key":"3434_CR4","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.3390\/cancers14174072","volume":"14","author":"L Oxburgh","year":"2022","unstructured":"Oxburgh L. The extracellular matrix environment of clear cell renal cell carcinoma. Cancers. 2022;14:4072.","journal-title":"Cancers"},{"key":"3434_CR5","doi-asserted-by":"publisher","first-page":"100603","DOI":"10.1016\/j.mcpro.2023.100603","volume":"22","author":"X Liu","year":"2023","unstructured":"Liu X, Zhang M, Shao C, Sun H, Zhang B, Guo Z, et al. Blood- and urine-based liquid biopsy for early-stage cancer investigation: taken clear renal cell carcinoma as a model. Mol Cell Proteom. 2023;22:100603.","journal-title":"Mol Cell Proteom"},{"key":"3434_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jprot.2018.04.029","volume":"191","author":"C Chinello","year":"2019","unstructured":"Chinello C, Stella M, Piga I, Smith AJ, Bovo G, Varallo M, et al. Proteomics of liquid biopsies: depicting RCC infiltration into the renal vein by MS analysis of urine and plasma. J Proteom. 2019;191:29\u201337.","journal-title":"J Proteom"},{"key":"3434_CR7","doi-asserted-by":"publisher","first-page":"1170567","DOI":"10.3389\/fonc.2023.1170567","volume":"13","author":"Y Yang","year":"2023","unstructured":"Yang Y, Pang Q, Hua M, Huangfu Z, Yan R, Liu W, et al. Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics. Front Oncol. 2023;13:1170567.","journal-title":"Front Oncol"},{"key":"3434_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","volume":"29","author":"AA Hakimi","year":"2016","unstructured":"Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer cell. 2016;29:104\u201316.","journal-title":"Cancer cell"},{"key":"3434_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/omi.2010.0094","volume":"15","author":"K Kim","year":"2011","unstructured":"Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. Omics. 2011;15:293\u2013303.","journal-title":"Omics"},{"key":"3434_CR10","doi-asserted-by":"crossref","unstructured":"Santorelli L, Stella M, Chinello C, Capitoli G, Piga I, Smith A et al. Does the urinary proteome reflect ccRCC stage and grade progression? Diagnostics. 2021;11:2369.","DOI":"10.3390\/diagnostics11122369"},{"key":"3434_CR11","doi-asserted-by":"crossref","unstructured":"Bifarin OO, Gaul DA, Sah S, Arnold RS, Ogan K, Master VA et al. Urine-based metabolomics and machine learning reveals metabolites associated with renal cell carcinoma stage. Cancers. 2021;13:6253.","DOI":"10.3390\/cancers13246253"},{"key":"3434_CR12","doi-asserted-by":"crossref","unstructured":"Santorelli L, Capitoli G, Chinello C, Piga I, Clerici F, Denti V et al. In-depth mapping of the urinary N-glycoproteome: distinct signatures of ccRCC-related progression. Cancers. 2020;12:239.","DOI":"10.3390\/cancers12010239"},{"key":"3434_CR13","doi-asserted-by":"crossref","unstructured":"Panebianco M, Ciccarese C, Strusi A, Beccia V, Carbone C, Agostini A et al. The role of the complement in clear cell renal carcinoma (ccRCC)-what future prospects are there for its use in clinical practice? Cancers. 2024;16:490.","DOI":"10.3390\/cancers16030490"},{"key":"3434_CR14","doi-asserted-by":"publisher","first-page":"111466","DOI":"10.1016\/j.yexcr.2019.06.011","volume":"382","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhu Y, Sheng Y, Xiao J, Xiao Y, Cheng N, et al. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3. Exp Cell Res. 2019;382:111466.","journal-title":"Exp Cell Res"},{"key":"3434_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","volume":"1","author":"M Ohh","year":"1998","unstructured":"Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell. 1998;1:959\u201368.","journal-title":"Mol Cell"},{"key":"3434_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","volume":"64","author":"A Nanda","year":"2004","unstructured":"Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, et al. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res. 2004;64:817\u201320.","journal-title":"Cancer Res"},{"key":"3434_CR17","doi-asserted-by":"publisher","first-page":"34361","DOI":"10.1074\/jbc.274.48.34361","volume":"274","author":"M R\u00fchl","year":"1999","unstructured":"R\u00fchl M, Sahin E, Johannsen M, Somasundaram R, Manski D, Riecken EO, et al. Soluble collagen VI drives serum-starved fibroblasts through S phase and prevents apoptosis via down-regulation of Bax. J Biol Chem. 1999;274:34361\u20138.","journal-title":"J Biol Chem"},{"key":"3434_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.canlet.2008.06.015","volume":"272","author":"D Matsuda","year":"2008","unstructured":"Matsuda D, Khoo SK, Massie A, Iwamura M, Chen J, Petillo D, et al. Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC. Cancer Lett. 2008;272:260\u20137.","journal-title":"Cancer Lett"},{"key":"3434_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.matbio.2014.01.004","volume":"35","author":"S Chen","year":"2014","unstructured":"Chen S, Young MF, Chakravarti S, Birk DE. Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. Matrix Biol. 2014;35:103\u201311.","journal-title":"Matrix Biol"},{"key":"3434_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","volume":"41","author":"Y Li","year":"2023","unstructured":"Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell. 2023;41:139\u201363.e117.","journal-title":"Cancer Cell"},{"key":"3434_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, et al. Integrated proteogenomic characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179:964\u2013983.","journal-title":"Cell"},{"key":"3434_CR22","doi-asserted-by":"publisher","first-page":"188559","DOI":"10.1016\/j.bbcan.2021.188559","volume":"1876","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Metabolic reprogramming in renal cancer: events of a metabolic disease. Biochim Biophys Acta Rev Cancer. 2021;1876:188559.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3434_CR23","doi-asserted-by":"publisher","unstructured":"Lucarelli G, Rutigliano M, Sallustio F, Ribatti D, Giglio A, Lepore Signorile M, et al. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma. Aging. 2018. https:\/\/doi.org\/10.18632\/aging.101685.","DOI":"10.18632\/aging.101685"},{"key":"3434_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ijc.22322","volume":"120","author":"CY Yoon","year":"2007","unstructured":"Yoon CY, Shim YJ, Kim EH, Lee JH, Won NH, Kim JH, et al. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer. 2007;120:897\u2013905.","journal-title":"Int J Cancer"},{"key":"3434_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen B. Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. 2018;18:33\u201350.","journal-title":"Nat Rev Cancer"},{"key":"3434_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","volume":"20","author":"SK Tan","year":"2023","unstructured":"Tan SK, Hougen HY, Merchan JR, Gonzalgo ML, Welford SM. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nat Rev Urol. 2023;20:48\u201360.","journal-title":"Nat Rev Urol"},{"key":"3434_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","volume":"56","author":"J Hu","year":"2024","unstructured":"Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, et al. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat Genet. 2024;56:442\u201357.","journal-title":"Nat Genet"},{"key":"3434_CR28","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/ndt\/gfr324","volume":"26","author":"H K\u00f6ppel","year":"2011","unstructured":"K\u00f6ppel H, Riedl E, Braunagel M, Sauerhoefer S, Ehnert S, Godoy P, et al. L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF-\u03b2 production and signalling. Nephrol Dial Transplant. 2011;26:3852\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"3434_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jcb.30403","volume":"124","author":"M Zhang","year":"2023","unstructured":"Zhang M, Wu Z, Salas SS, Aguilar MM, Trillos-Almanza MC, Buist-Homan M, et al. Arginase 1 expression is increased during hepatic stellate cell activation and facilitates collagen synthesis. J Cell Biochem. 2023;124:808\u201317.","journal-title":"J Cell Biochem"},{"key":"3434_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","volume":"29","author":"T Bertero","year":"2019","unstructured":"Bertero T, Oldham WM, Grasset EM, Bourget I, Boulter E, Pisano S, et al. Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy. Cell Metab. 2019;29:124\u201340.e110.","journal-title":"Cell Metab"},{"key":"3434_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/fcp.12163","volume":"30","author":"A Strilakou","year":"2016","unstructured":"Strilakou A, Perelas A, Lazaris A, Papavdi A, Karkalousos P, Giannopoulou I, et al. Immunohistochemical determination of the extracellular matrix modulation in a rat model of choline-deprived myocardium: the effects of carnitine. Fundamental Clin Pharmacol. 2016;30:47\u201357.","journal-title":"Fundamental Clin Pharmacol"},{"key":"3434_CR32","doi-asserted-by":"publisher","first-page":"e2207951","DOI":"10.1002\/adma.202207951","volume":"35","author":"S Jiang","year":"2023","unstructured":"Jiang S, Chen X, Lin J, Huang P. Lactate-oxidase-instructed cancer diagnosis and therapy. Adv Mater. 2023;35:e2207951.","journal-title":"Adv Mater"},{"key":"3434_CR33","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","volume":"88","author":"GL Semenza","year":"2000","unstructured":"Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000;88:1474\u201380.","journal-title":"J Appl Physiol"},{"key":"3434_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semcancer.2015.08.008","volume":"35","author":"P Gandellini","year":"2015","unstructured":"Gandellini P, Andriani F, Merlino G, D\u2019Aiuto F, Roz L, Callari M. Complexity in the tumour microenvironment: cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types. Semin Cancer Biol. 2015;35:96\u2013106.","journal-title":"Semin Cancer Biol"},{"key":"3434_CR35","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.immuni.2023.06.026","volume":"56","author":"MG Kiss","year":"2023","unstructured":"Kiss MG, Papac-Mili\u010devi\u0107 N, Porsch F, Tsiantoulas D, Hendrikx T, Takaoka M, et al. Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis. Immunity. 2023;56:1809\u201324.e1810.","journal-title":"Immunity"},{"key":"3434_CR36","first-page":"57","volume":"25","author":"J Jing","year":"2018","unstructured":"Jing J, Gao Y. Urine biomarkers in the early stages of diseases: current status and perspective. Discov Med. 2018;25:57\u201365.","journal-title":"Discov Med"},{"key":"3434_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11357-013-9562-7","volume":"36","author":"M Bakun","year":"2014","unstructured":"Bakun M, Senatorski G, Rubel T, Lukasik A, Zielenkiewicz P, Dadlez M, et al. Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction. Age. 2014;36:299\u2013311.","journal-title":"Age"},{"key":"3434_CR38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bbapap.2013.06.016","volume":"1844","author":"E Rodr\u00edguez-Su\u00e1rez","year":"2014","unstructured":"Rodr\u00edguez-Su\u00e1rez E, Siwy J, Z\u00fcrbig P, Mischak H. Urine as a source for clinical proteome analysis: from discovery to clinical application. Biochim Biophys Acta. 2014;1844:884\u201398.","journal-title":"Biochim Biophys Acta"},{"key":"3434_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/14789450.2015.1094380","volume":"12","author":"J Wu","year":"2015","unstructured":"Wu J, Gao Y. Physiological conditions can be reflected in human urine proteome and metabolome. Expert Rev Proteom. 2015;12:623\u201336.","journal-title":"Expert Rev Proteom"},{"key":"3434_CR40","doi-asserted-by":"crossref","unstructured":"Bond KH, Chiba T, Wynne KPH, Vary CPH, Sims-Lucas S, Coburn JM, et al. The extracellular matrix environment of clear cell renal cell carcinoma determines cancer associated fibroblast growth. Cancers. 2021;13:5873.","DOI":"10.3390\/cancers13235873"},{"key":"3434_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1126\/science.aat1699","volume":"361","author":"MD Young","year":"2018","unstructured":"Young MD, Mitchell TJ, Vieira Braga FA, Tran MGB, Stewart BJ, Ferdinand JR, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594\u20139.","journal-title":"Science"},{"key":"3434_CR42","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/ijc.23925","volume":"123","author":"O De Wever","year":"2008","unstructured":"De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008;123:2229\u201338.","journal-title":"Int J Cancer"},{"key":"3434_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/01.mnh.0000165887.75501.24","volume":"14","author":"D Turnberg","year":"2005","unstructured":"Turnberg D, Cook HT. Complement and glomerulonephritis: new insights. Curr Opin Nephrol Hypertens. 2005;14:223\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3434_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","volume":"19","author":"G Lucarelli","year":"2019","unstructured":"Lucarelli G, Loizzo D, Franzin R, Battaglia S, Ferro M, Cantiello F, et al. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma. Expert Rev Mol Diagn. 2019;19:397\u2013407.","journal-title":"Expert Rev Mol Diagn"},{"key":"3434_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","volume":"5","author":"P Jiang","year":"2014","unstructured":"Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein cell. 2014;5:592\u2013602.","journal-title":"Protein cell"},{"key":"3434_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1021\/pr101161u","volume":"10","author":"L Lin","year":"2011","unstructured":"Lin L, Huang Z, Gao Y, Yan X, Xing J, Hang W. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. J Proteome Res. 2011;10:1396\u2013405.","journal-title":"J Proteome Res"},{"key":"3434_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep28932","volume":"6","author":"K Saito","year":"2016","unstructured":"Saito K, Arai E, Maekawa K, Ishikawa M, Fujimoto H, Taguchi R, et al. Lipidomic signatures and associated transcriptomic profiles of clear cell renal cell carcinoma. Sci Rep. 2016;6:28932.","journal-title":"Sci Rep"},{"key":"3434_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41417-023-00688-x","volume":"31","author":"B Guo","year":"2024","unstructured":"Guo B, Zhao F, Zhang S. CILP is a potential pan-cancer marker: combined silico study and in vitro analyses. Cancer Gene Ther. 2024;31:119\u201330.","journal-title":"Cancer Gene Ther"},{"key":"3434_CR49","doi-asserted-by":"publisher","first-page":"112691","DOI":"10.1016\/j.biopha.2022.112691","volume":"147","author":"S Nomiri","year":"2022","unstructured":"Nomiri S, Hoshyar R, Chamani E, Rezaei Z, Salmani F, Larki P, et al. Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: in-silico and in-vivo study. Biomed Pharmacother. 2022;147:112691.","journal-title":"Biomed Pharmacother"},{"key":"3434_CR50","doi-asserted-by":"publisher","first-page":"11096","DOI":"10.18632\/aging.202765","volume":"13","author":"QH Chang","year":"2021","unstructured":"Chang QH, Mao T, Tao Y, Dong T, Tang XX, Ge GH, et al. Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma. Aging. 2021;13:11096\u2013119.","journal-title":"Aging"},{"key":"3434_CR51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3892\/etm.2024.12657","volume":"28","author":"J Gao","year":"2024","unstructured":"Gao J, Yu G, Yan Y, Hu W, Hu D, Wang W, et al. ITIH1 suppresses carcinogenesis in renal cell carcinoma through regulation of the NF\u2011\u03baB signaling pathway. Exp Therapeutic Med. 2024;28:368.","journal-title":"Exp Therapeutic Med"},{"key":"3434_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2011.07.021","volume":"315","author":"B Iovine","year":"2012","unstructured":"Iovine B, Iannella ML, Nocella F, Pricolo MR, Bevilacqua MA. Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production. Cancer Lett. 2012;315:122\u20138.","journal-title":"Cancer Lett"},{"key":"3434_CR53","doi-asserted-by":"crossref","unstructured":"Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012;72:5435\u20135440.","DOI":"10.1158\/0008-5472.CAN-12-0569"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03434-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:02:36Z","timestamp":1784109756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03434-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,5]]}},"alternative-id":["3434"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03434-w","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Institutional Review Boardof the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. All human subjects provided informed consent before participating in this study. The authors confirmed that all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}